APA (7 वां संस्करण) प्रशस्ति पत्र

Nash, P., Mease, P., Fleishaker, D., Wu, J., Coates, L., Behrens, F., . . . Kanik, K. (2020). Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: A randomised, placebo-controlled substudy of OPAL Balance. Elsevier.

शिकागो शैली (17वां संस्करण) प्रशस्ति पत्र

Nash, P., et al. Tofacitinib as Monotherapy Following Methotrexate Withdrawal in Patients with Psoriatic Arthritis Previously Treated with Open-label Tofacitinib Plus Methotrexate: A Randomised, Placebo-controlled Substudy of OPAL Balance. Elsevier, 2020.

एमएलए (9वां संस्करण) प्रशस्ति पत्र

Nash, P., et al. Tofacitinib as Monotherapy Following Methotrexate Withdrawal in Patients with Psoriatic Arthritis Previously Treated with Open-label Tofacitinib Plus Methotrexate: A Randomised, Placebo-controlled Substudy of OPAL Balance. Elsevier, 2020.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.